Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.

@article{Dallera2011TreatmentOM,
  title={Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.},
  author={Maria Dall'era and Eliza F. Chakravarty},
  journal={Current rheumatology reports},
  year={2011},
  volume={13 4},
  pages={308-16}
}
Despite large-scale efforts devoted to the conduct of clinical trials in systemic lupus erythematosus (SLE), no new therapy has been approved for treatment of this disease in more than 50 years. Increased understanding of the immunologic mechanisms underlying SLE has led to the development of a variety of biologic agents that target specific aspects of the adaptive and innate arms of the immune system, including B cells, T cells, dendritic cells, and various cytokines. One of these agents… CONTINUE READING